Minerva Neurosciences, Inc. ( NERV) - Stock Earnings
NERV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -6.2 million USD | — USD |
| 2023Q3 | -7.8 million USD | — USD |
| 2023Q4 | -9.0 million USD | — USD |
NERV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -49.9 million USD | 0 USD |
| 2022 | -39.0 million USD | 0 USD |
| 2023 | -30.0 million USD | — USD |
NERV
Price: $4.47
52 week price:
Earnings Per Share: -1.85 USD
P/E Ratio: -3.25
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 48300
Ebitda: -11.1 millionMarket Capitalization: 34.7 million